title: Highlights of the 2012 Congress of the Society for Melanoma Research, 8-11 November 2012, Hollywood, CA.
abstract: The 2012 Congress of the Society for Melanoma Research was attended by researchers with widespread expertise in basic, translational, and clinical research. Exciting research has led to the discovery of therapies to target mutations found in melanoma; however, it is clear that much still needs to be learned about how to use these therapies and the role of the microenvironment in therapy resistance and melanoma progression. This summary highlights recent discoveries in genetics and epigenetics, biology, immunotherapy, and targeted therapies for melanoma discussed at this year's meeting.
authors.affiliation: Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
authors.forename: Adina
authors.initials: A
authors.lastname: Vultur
authors.forename: Marie
authors.initials: M
authors.lastname: Webster
authors.forename: Jessie
authors.initials: J
authors.lastname: Villanueva
authors.forename: Dorothee
authors.initials: D
authors.lastname: Herlyn
mesh_terms: D000818:Animals; D006801:Humans; D008545:Melanoma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D012878:Skin Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*